In a groundbreaking study published in Nature Communications, researchers have uncovered compelling evidence that fasting is a critical component for realizing the full spectrum of benefits offered by calorie restriction in a widely used mouse model of Alzheimer’s disease. This study, conducted using the triple-transgenic (3xTg) mouse model, sheds new light on the interplay between dietary interventions and neurodegenerative diseases, suggesting that mere reduction in calorie intake may not suffice without the metabolic and physiological effects induced by fasting periods.
Calorie restriction (CR) has long been studied for its potential to extend lifespan and improve healthspan across various species. Previous research demonstrated that CR could ameliorate cognitive decline and reduce neuropathological hallmarks associated with Alzheimer’s disease, but the specific mechanisms and the role of fasting remained elusive. The work led by Babygirija, Han, Sonsalla, and colleagues elucidates a crucial nuance: it is not just the reduction in total calories but the intermittent absence of nutrient intake—that is, fasting—that drives many protective effects.
The team employed the 3xTg mouse model, which harbors three mutations associated with familial Alzheimer’s disease and displays both amyloid plaques and neurofibrillary tau tangles, mirroring key pathological features observed in humans. This model allows for testing interventions in a biologically relevant context. Notably, the researchers compared groups subjected to continuous calorie restriction without fasting and groups experiencing calorie restriction combined with intermittent fasting to disentangle the metabolic effects attributable to fasting itself.
Their findings were striking. Mice undergoing calorie restriction with fasting intervals exhibited marked improvements in cognitive performance as assessed by maze navigation and memory tests compared to mice subjected to calorie restriction alone without fasting. This cognitive improvement correlated with a significant reduction in amyloid-beta accumulation and tau phosphorylation in the hippocampus and cortex—regions critically involved in memory processing and known to degenerate in Alzheimer’s disease.
Mechanistically, the study suggests that fasting cycles activate key metabolic pathways that promote neuronal resilience and reduce neuroinflammation. Specifically, fasting was found to enhance autophagic flux, a cellular housekeeping process responsible for clearing misfolded proteins and damaged organelles. This enhancement is pivotal, as defective autophagy is implicated in the accumulation of toxic protein aggregates typical in neurodegenerative conditions.
In addition, fasting induced a metabolic switch from glucose utilization toward ketone body metabolism, which is believed to confer neuroprotective effects. Ketones serve as an alternative energy substrate and have been shown to reduce oxidative stress and inflammation in the brain. The researchers reported increased levels of circulating ketone bodies and upregulation of ketone metabolism-related genes in fasting mice, aligning with improved mitochondrial function and bioenergetic profiles.
Another significant observation was the modulation of inflammatory markers within the brain. The fasting regimen attenuated microglial activation and decreased pro-inflammatory cytokine expression. Given that chronic neuroinflammation exacerbates neuronal damage in Alzheimer’s pathology, these anti-inflammatory effects underscore the therapeutic potential of incorporating fasting into dietary interventions.
Importantly, the study emphasized that simply restricting calories without enforcing fasting did not replicate these neuroprotective effects. In fact, continuous calorie restriction, if coupled with frequent feeding, failed to induce ketogenesis or autophagy to the same extent as calorie restriction with fasting. This reinforces the notion that fasting imposes unique metabolic stresses that trigger adaptive, beneficial cellular responses beyond those achievable by caloric reduction alone.
These findings have crucial implications for human dietary recommendations, especially in the context of aging and Alzheimer’s disease prevention. The research suggests that time-restricted feeding schedules or intermittent fasting protocols, possibly combined with calorie restriction, could hold superior cognitive benefits by harnessing fasting-driven biological pathways. However, the authors caution that translation from mice to humans necessitates carefully designed clinical trials to evaluate safety, feasibility, and efficacy.
This study also prompts a reexamination of paradigms in nutritional neuroscience and aging research. While calorie restriction has dominated the field for decades, the distinct metabolic and signaling pathways activated by fasting warrant deeper exploration. Fasting appears to act as a hormetic stressor that enhances cellular defense mechanisms, promotes waste clearance, and recalibrates energy metabolism—processes that deteriorate with age and contribute to Alzheimer’s disease progression.
Further research inspired by these findings could explore how different fasting regimens, such as alternate-day fasting, prolonged fasting, or time-restricted feeding, synergize with calorie restriction to optimize brain health. Additionally, the potential interactions between fasting-induced metabolic changes and genetic risk factors for Alzheimer’s merit investigation, which could pave the way for personalized nutrition therapies.
Moreover, the work underscores the importance of investigating downstream molecular targets regulated by fasting, including AMP-activated protein kinase (AMPK), sirtuins, and mammalian target of rapamycin (mTOR), which orchestrate autophagy, inflammation, and metabolism. Understanding how these pathways are modulated during fasting in the aging brain could reveal new drug targets that mimic fasting’s beneficial effects without requiring stringent dietary compliance.
The study also raises fascinating questions about the peripheral-central axis in Alzheimer’s disease. The systemic metabolic shifts induced by fasting—such as improved insulin sensitivity, reduced adiposity, and altered gut microbiota—may indirectly influence central nervous system health. Future work integrating multi-system analyses will be crucial to unraveling these complex interactions.
While the data presented in the 3xTg mouse model are compelling, clinical translation remains challenging. Human fasting regimens must consider individual variability in metabolic health, nutrient requirements, and potential contraindications, especially in elderly or frail populations. Nevertheless, these insights offer hope for non-pharmacological interventions that could complement current approaches to mitigate Alzheimer’s disease progression.
In sum, this landmark research redefines our understanding of dietary modulation in neurodegenerative disease and highlights that fasting is not merely an adjunct but a pivotal factor in harnessing the protective benefits of calorie restriction. By illuminating the distinct metabolic and cellular pathways engaged by fasting, the study opens vibrant new avenues for tackling one of the most devastating diseases of aging.
As the global burden of Alzheimer’s continues to escalate, discoveries such as these spotlight lifestyle modifications as accessible, cost-effective tools to delay or reduce disease onset. With careful clinical translation, fasting-centered interventions may join the frontline in the fight against cognitive decline and dementia, revolutionizing preventative medicine.
Subject of Research: The role of fasting in enhancing the benefits of calorie restriction in the 3xTg mouse model of Alzheimer’s disease.
Article Title: Fasting is required for many of the benefits of calorie restriction in the 3xTg mouse model of Alzheimer’s disease.
Article References:
Babygirija, R., Han, J.H., Sonsalla, M.M. et al. Fasting is required for many of the benefits of calorie restriction in the 3xTg mouse model of Alzheimer’s disease. Nat Commun 16, 7147 (2025). https://doi.org/10.1038/s41467-025-62416-3
Image Credits: AI Generated
